NCT06912828 GWAS to Identify Predictive Genetic Factors for the Success of Dietary Intervention in the Treatment of IBS Symptoms
| NCT ID | NCT06912828 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Attikon Hospital |
| Condition | Irritable Bowel Syndrome (IBS) |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-09-15 |
| Primary Completion | 2026-09-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2024-09-15 with a primary completion date of 2026-09-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a GWAS that aims to identify possible single nucleotide polymorphisms (SNPs) that are associated with the response in a combined dietary pattern low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols and Meditteranean diet (MED-LFD) in a small group of patients with Irritable Bowel Syndrome (IBS).
Eligibility Criteria
Inclusion Criteria: * Fulfillment of the Rome IV criteria for IBS * Provision of written informed consent. * Commitment of availability throughout the study period. * IBS-SSS \> 175 Exclusion Criteria: * Any concomitant disease requiring specialized nutrition (e.g. renal failure, diabetes, celiac disease, cerebrovascular disease of the central nervous system, major surgical cavity). * Pregnancy. * Breastfeeding.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06912828 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Irritable Bowel Syndrome (IBS). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06912828 currently recruiting?
Yes, NCT06912828 is actively recruiting participants. Contact the research team at ktriant@med.uoa.gr for enrollment information.
Where is the NCT06912828 trial being conducted?
This trial is being conducted at Athens, Greece.
Who is sponsoring the NCT06912828 clinical trial?
NCT06912828 is sponsored by Attikon Hospital. The trial plans to enroll 100 participants.